Patients with cancer face a significantly higher risk of venous thromboembolism (VTE), but despite decades of awareness, robust evidence for inpatient thromboprophylaxis in cancer patients is still lacking. Alok Khorana, M.D., an expert on cancer-associated thrombosis, joins the podcast to unpack this critical issue and discuss how we can improve thrombosis prevention and treatment for patients with cancer. Plus, Khorana shares important insights from his recent editorial published in Research and Practice in Thrombosis and Haemostasis (RPTH) on the public health impact of cancer-associated VTE: www.rpthjournal.org/article/S2475-0379(25)00623-5/fulltext